analytics_image
Genomics in Cancer Care Market Size & Share | Growth Analysis 2035\
Vantage Market Research
Vantage Market Research

Reports - Genomics in Cancer Care Market

iconHealthcare

Genomics in Cancer Care Market

Genomics in Cancer Care Market by Product (Instruments, Consumables, Services), by Application (Diagnostics, Personalized Medicine, Drug Discovery & Development, Research), by Technology (Genome Sequencing, PCR, Microarrays, Nucleic Acid Extraction & Purification), by Region (North America, Europe, Asia Pacific, Latin America) - Historic Data (2021 - 2023) & Forecast Period (2025 - 2035)

ppt icon
pdf icon
xlsx icon
power bi icon
immediate delivery icon

Industry Leaders Trust Us For Actionable Intelligence

Revenue Insights

Market Size in 2024

USD 24.5 Billion

Market Size By 2035

USD 131.7 Billion

CAGR (2025 - 2035)

16.55%

Largest Region

North America

Fastest Region

Asia Pacific

Base Year

2024

Historic Data

2021 - 2023

Forecast Period

2025 - 2035

Segments Covered

By Product, By Application, By Technology, By Region

Report Coverage

The final deliverable will encompass both quantitative and qualitative data, providing a comprehensive analysis of the market. The scope is customizable.

Overview


Market Synopsis:

The global Genomics in Cancer Care Market is valued at USD 24.5 Billion in 2024 and is projected to reach a value of USD 131.7 Billion by 2035 at a CAGR (Compound Annual Growth Rate) of 16.55% between 2025 and 2035. In the next years, the market is likely to develop due to rising demand for diagnostics and the availability of technologically improved and cost-effective diagnostic technology. The expansion of genomics in the cancer care market is attributed to rising investments in the biotech and pharmaceutical industries, as well as increased R&D activities for the development of novel treatment treatments. Furthermore, over the projection period, rising need for personalised medication is expected to drive demand.

Genomics in Cancer Care Market Size, 2024 To 2035 (USD Billion)

In the most hopeful scenario, the COVID-19 pandemic would have a long-term positive impact on the global Genomics in Cancer Care business. In early 2020, the COVID-19 pandemic had a detrimental impact on the Genomics in Cancer Care market, as most dental offices, clinics, and laboratories were forced to close due to lockdowns and quarantine regulations in many regions of the world. However, most regions, particularly North America and Europe, are recovering as laboratory services has return to normalcy.

Supportive Government Policies

The market is fueled by government regulations that favour synthetic biology. Investors have moved their focus to synthetic biology in recent years as demand for the technology has grown. By 2020, the synthetic biology field will have received around USD 8 billion in governmental and private funding. In terms of fresh growth potential, the ongoing COVID-19 epidemic has been beneficial to the market. Scientific communities are researching uncharted territory in the space, resulting in increased revenue. Researchers at the National Institute of Standards and Technology (NIST), for example, have created synthetic COVID-19 viral gene segments to aid diagnostic developers in developing more reliable and accurate diagnostic tests for the disease.

Long Approval Time

Long approval times for Genomics in Cancer Care and the goods synthesised with these products limit product producers' ability to gain a competitive advantage in the market, reducing total market size and so posing a hurdle to the Genomics in Cancer Care markets growth.

Also, the high cost associated with genomics equipment may create hindrances in the growth of the genomics in cancer care market in the forecast period.

The Genomics in Cancer Care market scope can be tabulated as below:

Market Segmentation:

The Genomics in Cancer Care Market is segmented by Product Type, Application, Technology, and Geography. By product type, the market is segmented into Instruments, Consumables, Services. By technology, the market is segmented into PCR, Microarrays, Genome Sequencing, and Others. By Application into Diagnostics, Personalized medicine, Drug discovery & development and Research. Based on Region, the Genomics in Cancer Care Market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

North America to Continue Dominating the Genomics in Cancer Care Market

In terms of sales, North America dominated the industry in 2020, accounting for about 33.6% of the total. The greatest market share of this region is due to a higher level of awareness regarding cancer genomics and a burgeoning biotechnology industry. The thriving genomics industry, combined with the presence of untapped potential, government assistance, and continuously growing healthcare infrastructure, is likely to drive significant growth in Asia-Pacific throughout the projection period.

Key Players:

Key participants operating in the Genomics in Cancer Care market are: Agilent Technologies

The Genomics in Cancer Care market is segmented as follows:

Market Segmentation

ParameterDetails
Segment Covered

By Product

  • Instruments (33.4%)
  • Consumables
  • Services

By Application

  • Diagnostics
  • Personalized Medicine
  • Drug Discovery & Development
  • Research (12.3%)

By Technology

  • Genome Sequencing (24.1%)
  • PCR
  • Microarrays
  • Nucleic Acid Extraction & Purification
  • Other

By Region

  • North America (U.S., Canada, Mexico) (33.6%)
  • Europe (Germany, France, U.K., Italy, Spain, Nordic Countries, Benelux Union, Rest of Europe)
  • Asia Pacific (China, Japan, India, New Zealand, Australia, South Korea, South-East Asia, Rest of Asia Pacific)
  • Latin America (Brazil, Argentina, Rest of Latin America)
  • Middle East & Africa
Companies Covered
  • Agilent Technologies
  • Illumina
  • Inc.
  • Pacific Biosciences
  • Inc.
  • ThermoFisher Scientific Inc.
  • Intrexon Bioinformatics Germany GmbH are the major companies operating in Global Genomics in Cancer Care Market.
Customization ScopeEnjoy complimentary report customization—equivalent to up to 8 analyst working days—with your purchase. Customizations may include additions or modifications to country, regional, or segment-level data.
Pricing and purchase optionsAccess flexible purchase options tailored to your specific research requirements. Explore purchase options

Report coverage & Deliverables

Our PDF Reports And Online Dashboard Will Help You Stay Ahead In The Market.

    Key features include:

  • Check
    Competitive benchmarking
  • Check
    Historical data and future forecasts
  • Check
    Company-wise revenue breakdown
  • Check
    Regional growth opportunities
  • Check
    Latest market trends and dynamics
  • Check
    Impact of emerging technologies like AI and automation
  • Check
    Key regulatory updates and ESG considerations

FAQ‘s

vantage logo

Vantage Market Research & Consultancy Services is all about providing accurate and reliable market intelligence to its clients for the seamless execution of their business growth strategies.

© 2025 Vantage Market Research. All right reserved
Secured Bysecured by